UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
☒QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2026
Or
☐Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
For the transition period from to .
Commission file number: 002-25577
DIODES INCORPORATED
(Exact name of registrant as specified in its charter)
Delaware
95-2039518
(State or other jurisdiction of incorporation or organization)
(I.R.S. Employer Identification Number)
4949 Hedgcoxe Road, Suite 200, Plano, Texas
75024
(Address of principal executive offices)
(Zip code)
(972) 987-3900
(Registrant’s telephone number, including area code)
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, Par Value $0.66 2/3
DIOD
The NASDAQ Stock Market LLC
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act:
Large accelerated filer
☒
Accelerated filer
☐
Non-accelerated filer
Smaller reporting company
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
The number of shares of the registrant’s Common Stock outstanding as of October 30, 2026 was 45,700,303.
DIODES INCORPORATED AND SUBSIDIARIES
Table of Contents
Page
Part I – Financial Information
Item 1. Condensed Consolidated Financial Statements (Unaudited)
3
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
28
Item 3. Quantitative and Qualitative Disclosures About Market Risk
35
Item 4. Controls and Procedures
Part II – Other Information
Item 1. Legal Proceedings
36
Item 1A. Risk Factors
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
38
Item 3. Defaults Upon Senior Securities
Item 4. Mine Safety Disclosures
Item 5. Other Information
Item 6. Exhibits
39
Signatures
41
PART I—FINANCIAL INFORMATION
Item 1. Condensed Consolidated Financial Statements.
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)
(In thousands, except per share data)
September 30,
December 31,
2026
2025
Assets
Current assets:
Cash and cash equivalents
$
563,382
367,212
Restricted cash
2,768
5,134
Short-term investments
11,468
9,817
Accounts receivable, net of allowances of $4,539 and $4,095, respectively
348,406
307,055
Inventories
535,035
471,546
Prepaid expenses and other
101,662
96,198
Total current assets
1,562,721
1,256,962
Property, plant, and equipment, net
688,017
649,605
Deferred tax assets
66,464
59,297
Goodwill
263,063
183,437
Intangible assets, net
231,380
45,455
Equity investments
163,915
156,272
Operating lease assets
64,957
38,740
Other long-term assets
50,375
58,332
Total assets
3,090,892
2,448,100
Liabilities
Current liabilities:
Lines of credit
21,029
30,264
Accounts payable
203,849
149,376
Operating lease liabilities, current
14,037
10,666
Accrued liabilities and other
229,914
170,256
Income tax payable
37,897
16,336
Current portion of long-term debt
1,571
1,442
Total current liabilities
508,297
378,340
Long-term debt, net of current portion
381,909
24,224
Deferred tax liabilities
50,318
6,145
Unrecognized tax benefits
21,917
23,454
Operating lease liabilities
52,180
28,890
Other long-term liabilities
54,151
48,638
Total liabilities
1,068,772
509,691
Commitments and contingencies (See Note 10)
-
Stockholders' equity
Preferred stock - par value $1.00 per share; 1,000 shares authorized; no shares issued or outstanding
Common stock - par value $0.66 2/3 per share; 70,000 shares authorized; 56,161 and 55,883, shares issued; 45,693 and 45,875, shares outstanding, respectively
37,444
37,259
Additional paid-in capital
555,536
538,087
Retained earnings
1,890,761
1,785,439
Treasury stock, at cost, 10,468 shares and 10,008 shares, respectively
(417,143
)
(371,914
Accumulated other comprehensive loss
(117,300
(110,747
1,949,298
1,878,124
Noncontrolling interest
72,822
60,285
Total equity
2,022,120
1,938,409
Total liabilities and stockholders' equity
The accompanying notes are an integral part of these condensed consolidated financial statements.
-3-
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
Three Months Ended
Nine Months Ended
Net sales
532,587
392,170
1,383,583
1,090,495
Cost of goods sold
340,122
271,682
914,760
749,989
Gross profit
192,465
120,488
468,823
340,506
Operating expenses
Selling, general, and administrative
80,220
60,498
214,307
178,667
Research and development
43,856
41,861
125,122
121,025
Amortization of acquisition related intangible assets
5,162
5,850
13,017
17,513
(Gain) loss on disposal of fixed assets
(185
699
(105
700
Other operating (income) expense
(1
8
14
344
Total operating expense
129,052
108,916
352,355
318,249
Income from operations
63,413
11,572
116,468
22,257
Other income (expense)
Interest income
4,798
8,487
15,791
21,324
Interest expense
(813
(503
(1,829
(1,476
Foreign currency (loss), net
(2,977
(3,328
(7,371
(9,943
Unrealized (loss) gain on investments
(6,041
2,391
16,427
28,004
Impairment of equity investment
(1,249
(5,817
Gain on disposal of subsidiary
3,841
13,730
Other income
765
845
1,326
1,825
Total other (expense) income
(427
7,892
26,936
47,647
Income before income taxes, equity in net earnings of equity investments, and noncontrolling interest
62,986
19,464
143,404
69,904
Income tax provision
14,091
3,555
24,938
12,638
Equity in net earnings of equity investments
(2,369
(432
(7,072
(416
Net income
46,526
15,477
111,394
56,850
Less net income attributable to noncontrolling interest
(2,814
(1,199
(6,072
(911
Net income attributable to common stockholders
43,712
14,278
105,322
55,939
Earnings per share attributable to common stockholders:
Basic
0.95
0.31
2.29
1.21
Diluted
2.27
1.20
Number of shares used in earnings per share computation:
45,878
46,383
45,906
46,384
46,247
46,437
46,333
46,454
-4-
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(In thousands)
Unrealized (loss) gain on defined benefit plan, net of tax
(85
2,754
2,298
7,014
Unrealized gain (loss) on derivative instruments, net of tax
1
17,485
(2,782
3,700
Reclassification adjustment to interest income
(1,800
(6,176
(8,418
(15,484
Unrealized foreign currency gain (loss), net of tax
3,601
(20,453
2,349
44,825
Comprehensive income
48,243
9,087
104,841
96,905
Less: Comprehensive (income) attributable to noncontrolling interest
Total comprehensive income attributable to common stockholders
45,429
7,888
98,769
95,994
-5-
CONDENSED CONSOLIDATED STATEMENTS OF EQUITY
Common stock
Treasury stock
Additional paid-in
Retained
Accumulated other comprehensive
Total Diodes Incorporated stockholders'
Noncontrolling
Total
Shares
Amount
capital
earnings
loss
equity
interest
Balance, June 30, 2026
55,977
37,321
(10,108
(382,143
569,091
1,847,049
(119,017
1,952,301
70,008
2,022,309
Total comprehensive income
1,717
2,814
Net changes in noncontrolling interest
(74
Common stock issued for share-based plans
184
123
(123
Purchase of capped call, net of tax
(17,301
Share-based compensation
9,400
Stock buyback
(360
(35,000
Tax related to net share settlement
(5,457
Balance, September 30, 2026
56,161
(10,468
Balance, December 31, 2025
55,883
(10,008
Total comprehensive income (loss)
(6,553
6,072
13,994
6,465
20,459
278
185
28,270
(460
(45,229
(7,329
-6-
CONDENSED CONSOLIDATED STATEMENTS OF EQUITY (CONT.)
Balance, June 30, 2025
55,710
37,142
(9,499
(348,104
527,385
1,760,959
(100,279
1,877,103
57,068
1,934,171
(6,390
1,199
172
115
(115
6,826
(2,663
Balance, September 30, 2025
55,882
37,257
531,433
1,775,237
(106,669
1,889,154
58,267
1,947,421
Balance, December 31, 2024
55,621
37,083
(9,288
(338,100
523,744
1,719,298
(146,724
1,795,301
73,646
1,868,947
40,055
911
(6,855
(16,290
(23,145
261
174
(174
19,005
(211
(10,004
(4,287
-7-
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
Cash flows from operating activities
Adjustments to reconcile net income to net cash flows from operating activities, net of effects of acquisitions
Depreciation
93,311
90,974
Amortization of intangible assets
Share-based compensation expense
Deferred income taxes
(2,076
(304
Investment gain
(9,244
(27,613
Gain on sale of subsidiary
(3,841
(13,730
1,249
5,836
Interest income from derivative financial instruments
Other
3,458
381
Changes in operating assets:
Change in accounts receivable
(37,849
27,778
Change in inventory
(35,056
12,645
Change in other operating assets
(224
1,859
Changes in operating liabilities:
Change in accounts payable
53,370
10,049
Change in accrued liabilities
2,489
(12,671
Change in income tax payable
20,479
(97
Change in other operating liabilities
(276
3,706
Net cash flows from operating activities
229,948
177,397
Cash flows from investing activities
Acquisition, net of cash acquired
(236,233
(5,160
Purchases of property, plant, and equipment
(118,742
(52,660
Proceeds from sale of property, plant, and equipment
544
5,660
Proceeds from sale of short-term investments
1,005
Proceeds from maturity of short-term securities
1,893
7,629
Purchases of short-term investments
(2,287
(8,919
Purchases of equity securities
(49,303
Proceeds from sale of subsidiary
2,787
15,958
Cash received (paid) for hedge termination
7,710
(6,635
(1,193
(540
Net cash flows from investing activities
(344,932
(93,970
Cash flows from financing activities
Advances on lines of credit and short-term debt
38,775
34,036
Repayments of lines of credit and short-term debt
(47,571
(34,906
Proceeds from long-term debt
382,032
6,539
Repayments of long-term debt
(13,818
(4,097
Debt issuance costs
(11,722
Capped call payment
(21,900
Repayment of and proceeds from finance lease obligation
421
(73
Taxes paid related to net share settlement
24,937
(18,004
Repurchase of common stock
(45,197
3,485
(28
Net cash flows from financing activities
302,113
(30,824
Effect of exchange rate changes on cash and cash equivalents
6,675
14,720
Change in cash and cash equivalents, including restricted cash
193,804
67,323
Cash and cash equivalents, beginning of period, including restricted cash
372,346
314,724
Cash and cash equivalents, end of period, including restricted cash
566,150
382,047
-8-
Supplemental Cash Flow Information
Interest paid during the period
825
1,237
Taxes paid during the period
12,235
21,205
Non-cash investing and financing activities:
Accounts payable balance related to the purchase of property, plant, and equipment
30,149
12,237
Dividend payable to noncontrolling interest
3,153
-9-
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE 1 – Summary of Operations and Significant Accounting Policies
Background
Diodes Incorporated (Nasdaq: DIOD), delivers high-quality semiconductor products to the world’s leading companies in the automotive, industrial, computing, consumer electronics, and communications markets. We leverage our expanded product portfolio of analog and power solutions combined with a flexible hybrid manufacturing model that meet customers’ needs. Our broad range of application-specific products, delivered through a total solutions sales approach and supported by global operations including engineering, testing, manufacturing, and customer service, enable us to be a premier provider for high-growth markets.
Basis of Presentation
The unaudited condensed consolidated balance sheet and financial data at December 31, 2025 are derived from audited financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2025 filed with the Securities and Exchange Commission (“SEC”) on February 10, 2026 (“Form 10-K”). The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with United States Generally Accepted Accounting Principles (“GAAP”) for interim financial information and with the instructions to Form 10-Q. Accordingly, the unaudited condensed consolidated financial statements do not include all information and footnotes necessary for a fair statement of financial position, operating results, and cash flows in conformity with GAAP for complete financial statements. These condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and related notes contained in our Form 10-K. All significant intercompany balances and transactions have been eliminated in consolidation. In the opinion of management, all adjustments (consisting of normal recurring adjustments and accruals) considered necessary for a fair statement of the operating results for the periods presented have been included in the interim periods. Operating results for the three and nine months ended September 30, 2026 are not necessarily indicative of the results that may be expected for other interim periods or the year ending December 31, 2026.
The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Actual results could differ from these estimates. As permitted under GAAP, interim accounting for certain expenses, including income taxes, are based on full year forecasts. For interim financial reporting purposes, income taxes are recorded based upon estimated annual effective income tax rates taking into consideration discrete items occurring in a quarter.
Dollar amounts and share amounts are presented in thousands, except per share amounts, unless otherwise noted. Certain prior period balances were reclassified to conform to the current condensed consolidated financial statement presentation.
Recently Issued Accounting Pronouncements
The Financial Accounting Standards Board (“FASB”) issued the following Accounting Standards Updates (“ASU”) which could have potential impact to the Company’s consolidated financial statements:
In May 2026, the FASB issued ASU 2026-02, Environmental Credits and Environmental Credit Obligations (Topic 818), which establishes new guidance for the recognition, measurement, presentation, and disclosure of environmental credits and environmental credit obligations. The guidance applies to environmental credits that are acquired, generated, granted, or received by an entity and to obligations that may be settled using such credits.
The standard is effective for public business entities for fiscal years beginning after December 15, 2027, including interim periods within those fiscal years. Early adoption is permitted. The Company is currently evaluating the effect that adoption of ASU 2026-02 will have on its consolidated financial statements and related disclosures.
In December 2025, the FASB issued ASU 2025-09 to amend certain aspects of its hedge accounting guidance to better reflect an entity’s risk management activities in the financial statements. The guidance expands the hedged risks permitted to be aggregated in a group of individual forecasted transactions and increases the variable price components eligible to be designated as the hedged risk in the forecasted purchase or sale of non-financial assets. For public business entities, the provisions of ASU 2025-09 are effective for fiscal years beginning after December 15, 2026. Early adoption is permitted. The Company has adopted the provisions set forth in ASU 2025-09 in the three months ended June 30, 2026, which did not have a material impact on the Company’s consolidated financial statements.
In July 2025, the FASB issued ASU 2025-05, “Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets” (“ASU 2025-05”). ASU 2025-05 provides a practical expedient that all entities can use when estimating expected credit losses for current accounts receivable and current contract assets arising from transactions accounted for under ASC 606, Revenue from Contracts with Customers. Under this practical expedient, an entity is allowed to assume that the current conditions it has applied in determining credit loss allowances for current accounts receivable and current contract assets remain
-10-
unchanged for the remaining life of those assets. ASU 2025-05 is effective for fiscal years beginning after December 15, 2025, and interim reporting periods in those years. Entities that elect the practical expedient and, if applicable, make the accounting policy election are required to apply the amendments prospectively. In the first quarter of 2026, the Company adopted this standard which did not have a material impact on the Company’s consolidated financial statements.
In May 2025, the FASB issued ASU 2025-03, “Business Combination and Consolidation: Determining the Accounting Acquirer in the Acquisition of a Variable Interest Entity” (“ASU 2025-03”). ASU 2025-03 provides clarifying guidance on determining the accounting acquirer in certain transactions involving VIEs. The update aims to improve consistency and comparability in financial reporting, especially when companies merge with a special-purpose acquisition company (“SPAC”). ASU 2025-03 requires entities to apply the same factors used for determining the accounting acquirer in other acquisition transactions. Essentially, it aims to make financial reporting more comparable and decision-useful for investors by ensuring that the accounting acquirer is appropriately identified in acquisitions of VIEs, particularly in SPAC transactions. ASU 2025-03 is effective for fiscal years beginning after December 15, 2026 including interim periods within those annual periods, with early adoption permitted. The Company is currently evaluating the impact this amended guidance may have on its consolidated financial statements.
In November 2024, the FASB issued ASU 2024-03, Income Statement—Reporting Comprehensive Income—Expense Disaggregation Disclosures (Subtopic 220-40). The amendments in this update require that at each interim and annual reporting period an entity disclose:
The amendments in this update are effective for annual reporting periods beginning after December 15, 2026, and interim reporting periods beginning after December 15, 2027. Early adoption is permitted. The Company is currently evaluating the impact this amended guidance may have on its consolidated financial statements.
NOTE 2 – Earnings per Share and Equity
Earnings per share (“EPS”) is calculated by dividing net income attributable to common stockholders by the weighted-average number of shares of Common Stock outstanding during the period. Diluted EPS is calculated similarly but includes potential dilution from the exercise of stock options and stock awards, except when the effect would be anti-dilutive. No dividends were paid on our Common Stock in any of the periods presented in this report.
On May 8, 2025, the Board of Directors authorized a share repurchase program pursuant to which the Company may repurchase shares of its common stock from time to time in the open market or through privately negotiated transactions, subject to market conditions, applicable legal requirements, and other factors. The repurchased shares are held as treasury stock and are excluded from shares outstanding for purposes of calculating basic and diluted earnings per share from the date of repurchase. The following table sets forth repurchase activity under the program during the periods presented:
Shares repurchased
360.12
459.24
210.94
Aggregate purchase price
35,000
45,197
10,004
Average purchase price per share
97.19
98.42
47.42
During the nine months ended September 30, 2026, our 53% owned subsidiary, ERIS, reduced its ownership interest in one of its subsidiaries from approximately 96% to approximately 77%, which increased the Company’s noncontrolling interest in ERIS by approximately $9.9 million. The Company received approximately $25.3 million.
On August 18, 2026, the Company issued $375.0 million aggregate principal amount of 0.00% Convertible Senior Notes due 2031 (the "Convertible Senior Notes"). The Convertible Senior Notes require the Company to settle the principal amount in cash upon conversion, with any conversion premium payable in cash, shares of the Company's common stock, or a combination thereof.
The Company accounts for the potential dilutive effect of the Convertible Senior Notes in accordance with the if-converted method.
-11-
Because the principal amount of the Convertible Senior Notes is required to be settled in cash, only the incremental shares, if any, attributable to the conversion premium are included in diluted weighted-average shares outstanding, and no adjustment is made to the numerator for interest expense. Shares issuable upon conversion are included in diluted weighted-average shares outstanding only to the extent required under the if-converted method.
For the three and nine months ended September 30, 2026, no incremental shares attributable to the Convertible Senior Notes were included in diluted earnings per share because the average market price of the Company's common stock did not exceed the conversion price during the applicable periods.
In connection with the issuance of the Convertible Senior Notes, the Company entered into Capped Call Transactions (the "Capped Call Transactions") that are expected to reduce potential dilution to the Company's common stock upon conversion of the Convertible Senior Notes and/or offset cash payments in excess of the principal amount of converted Convertible Senior Notes. The Capped Call Transactions have an initial strike price of approximately $145.79 per share, which corresponds to the initial conversion price of the Convertible Senior Notes, and an initial cap price of approximately $194.38 per share, in each case subject to certain adjustments under the terms of the Capped Call Transactions. The Capped Call Transactions initially cover, subject to anti-dilution adjustments, approximately 2.6 million shares of common stock underlying the Convertible Senior Notes. The Company paid premiums of approximately $21.9 million for the Capped Call Transactions, which were recorded as a reduction to additional paid-in capital, net of the related deferred tax benefit. Because the Capped Call Transactions meet the criteria for classification within stockholders’ equity and are classified within stockholders' equity, they are not subsequently remeasured at fair value. The Capped Call Transactions are excluded from the calculation of diluted earnings per share because their inclusion would be antidilutive. The table below sets forth the reconciliation between net income and the weighted-average shares outstanding used for calculating basic and diluted EPS:
Earnings (numerator)
Shares (denominator)
Weighted-average common shares outstanding (basic)
Dilutive effect of stock options and stock awards outstanding
369
54
427
70
Adjusted weighted-average common shares outstanding (diluted)
Earnings per share attributable to common stockholders
Stock options and stock awards excluded from EPS calculation because the effect would be anti-dilutive
356
273
127
674
NOTE 3 - Fair Value Measurements
Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date.
We use valuation techniques that are consistent with the market approach, the income approach and/or the cost approach. The market approach uses prices and other relevant information generated by market transactions involving identical or comparable assets and liabilities. The income approach uses valuation techniques to convert future amounts, such as cash flows or earnings, to a single present amount on a discounted basis. The cost approach is based on the amount that currently would be required to replace the service capacity of an asset (replacement costs). Valuation techniques should be consistently applied. Inputs to valuation techniques refer to the assumptions that market participants would use in pricing the asset or liability. Inputs may be observable, meaning those that reflect the assumptions market participants would use in pricing the asset or liability developed based on market data obtained from independent sources, or unobservable, meaning those that reflect the reporting entity’s own assumptions about the assumptions market participants would use in pricing the asset or liability developed based on the best information available in the circumstances. These two types of inputs create a three-tier fair value hierarchy that gives the highest priority to quoted prices in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The fair value hierarchy is as follows:
Level 1 Inputs - Unadjusted quoted prices in active markets for identical assets or liabilities that the reporting entity has the ability to access at the measurement date.
-12-
Level 2 Inputs - Inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly. These include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability (for example, interest rates, volatilities, prepayment speeds, loss severities, credit risks and default rates) or inputs that are derived principally from or corroborated by observable market data by correlation or other means.
Level 3 Inputs - Significant unobservable inputs that reflect an entity’s own assumptions that market participants would use in pricing the assets or liabilities.
As of September 30, 2026, we had cash and cash equivalents, short-term, and long-term investments. Long-term investments are included within Equity investments on the consolidated balance sheet. Trading securities held at September 30, 2026, were purchased on the open market and unrealized gains and losses are included in Other income (expense). The trading securities are valued under the fair value hierarchy using Level 1 Inputs. Short-term investments consist of investments such as time deposits, which are highly liquid with maturity dates greater than three months at the date of purchase. Generally, we can access these short-term investments in a relatively short amount of time but in doing so we generally forfeit a portion of earned and future interest income. Deferred compensation investments consist primarily of life insurance policies, but may also include investments in the Company’s stock, mutual funds and cash. See Note 12 for additional information related to our deferred compensation program and Note 11 for additional information related to our derivative financial instruments. The short-term investments, long-term investments and deferred compensation investments are valued under the fair value hierarchy using Level 1 and Level 2 Inputs.
Financial assets and liabilities carried at fair value as of September 30, 2026, are classified in the following table:
Description
Fair Market Value
Quoted Prices in Active Markets for Identical Assets (Level 1)
Significant Other Observable Inputs (Level 2)
SignificantUnobservableInputs (Level 3)
Total Changes in Fair Values Included in Year-to-Date Earnings
Cash and cash equivalents:
Money markets
426
106
Certificates of deposit and share certificates
1,224
Corporate bonds
1,979
Other fixed income securities
3,489
U.S. Treasury/Agency Securities
28,051
Total cash and cash equivalents
35,169
(47
Long-term investments
36,518
16,368
Collared forward liability
(964
Commodity swap contracts
(884
Deferred compensation investments
21,568
1,931
19,637
1,069
ElevATE contingent consideration
4,876
107,751
85,086
17,789
17,496
Financial assets and liabilities carried at fair value as of December 31, 2025, are classified in the following table:
Total Changes in Fair Values Included in Current Period Earnings
20,574
(4,754
Collared forward asset
11,454
(2,558
19,959
1,196
18,763
2,244
59,246
31,587
27,659
(2,510
Certain financial assets and financial liabilities are measured at fair value on a non-recurring basis; that is, the instruments are not
-13-
measured at fair value on an ongoing basis, but are subject to fair value adjustments in certain circumstances (for example, when there is evidence of impairment). We believe the carrying amount of borrowings under our Revolving Credit Facility and notes payable approximates fair value due to the variable nature of the applicable interest rates. The estimated fair value of such borrowings would be classified within Level 2 of the fair value hierarchy. The Company's Convertible Senior Notes are accounted for as a single liability measured at amortized cost. At September 30, 2026, the carrying amount of the Convertible Senior Notes was approximately $364.9 million, net of unamortized debt issuance costs, with an estimated fair value of $377.5 million. The fair value was estimated using observable market data, including indicative pricing obtained from market participants and is classified within Level 2 of the fair value hierarchy. Financial assets and financial liabilities measured at fair value on a non-recurring basis were not significant as of September 30, 2026 and December 31, 2025.
NOTE 4 – Inventories
The table below sets forth inventories which are stated at the lower of cost or net realizable value:
September 30, 2026
December 31, 2025
Finished goods
157,620
171,369
Work-in-progress
120,966
91,143
Raw materials
256,449
209,034
NOTE 5 – Goodwill and Intangible Assets
The increase in goodwill of approximately $80.7 million and the acquisition of approximately $199.0 million of identifiable intangible assets were related to the acquisition of ElevATE Semiconductor, Inc. ("ElevATE"). Refer to Note 15 for additional information regarding the acquisition.
The table below sets forth the changes in goodwill:
Balance at December 31, 2025
Acquisitions
80,689
Foreign currency translation and other adjustments
(1,063
Balance at September 30, 2026
The table below sets forth the value of intangible assets, other than goodwill:
Intangible assets subject to amortization:
Gross carrying amount
469,997
270,997
Accumulated amortization
(239,562
(226,544
Foreign currency translation adjustment
(8,396
(8,370
Total intangible assets subject to amortization
222,039
36,083
Intangible assets with indefinite lives:
10,303
(962
(931
Total intangible assets with indefinite lives
9,341
9,372
Total intangible assets, net
The table below sets forth amortization expense related to intangible assets subject to amortization:
Amortization expense
Three Months Ended September 30,
Nine Months Ended September 30,
-14-
NOTE 6 – Income Tax Provision
The table below sets forth information related to our income tax expense:
Domestic pre-tax income (loss)
32,964
(27,451
55,409
62,798
Foreign pre-tax income
27,653
46,483
80,923
6,690
Effective tax rate
23.2
%
18.7
18.3
18.2
Impact of tax holidays on tax expense
(869
(353
(1,714
(816
Earnings per share impact of tax holidays:
0.02
0.01
0.04
For the three months ended September 30, 2026, the effective tax rate differs from the 21% U.S. statutory income tax rate primarily due to the impact of nondeductible investment losses included in pretax income, partially offset by research and development tax incentives and changes in unrecognized tax benefits.
For the nine months ended September 30, 2026, the effective tax rate differs from the 21% U.S. statutory income tax rate primarily due to the impact of research and development tax incentives and nontaxable investment gains included in pretax income, partially offset by nondeductible compensation.
For the three and nine months ended September 30, 2025, the effective tax rate differs from the 21% U.S. statutory income tax rate primarily due to the impact of research and development tax incentives and changes in conclusions regarding the realizability of certain deferred tax assets, partially offset by taxes on foreign income and nondeductible compensation.
The increase in effective tax rate for the three and nine months ended September 30, 2026, when compared to the three and nine months ended September 30, 2025, is primarily due to the change in pre-tax earnings during the comparable periods, including the geographical mix of pre-tax income and loss across tax jurisdictions.
NOTE 7 – Share-Based Compensation
The table below sets forth information related to our share-based compensation expense:
734
584
1,830
1,650
7,089
4,909
22,555
13,557
1,577
1,333
3,885
3,798
Total share-based compensation expense
Share Grants. Share grants consist of restricted stock awards, restricted stock units (“RSUs”) and performance stock units (“PSUs”). Restricted stock awards and RSUs generally vest in equal annual installments over a four-year period and are measured based
-15-
on the fair market value of the underlying stock on the date of grant. Compensation expense is recognized on a straight-line basis over the requisite four-year service period. All new grants are awarded under the Company’s 2022 Equity Incentive Plan.
PSUs are measured based on the fair market value of the underlying stock on the date of grant, and compensation expense is recognized over the three-year performance period, with adjustments made to the expense to recognize the probable payout percentage.
As of September 30, 2026, total unrecognized share-based compensation expense related to share grants was approximately $84.6 million, before income taxes, and is expected to be recognized over a weighted average period of approximately 2.5 years.
NOTE 8 – Enterprise-Wide Segment Information and Net Sales
Segment Reporting. For financial reporting purposes, we operate in a single segment, standard semiconductor products, through our various manufacturing and distribution facilities. One segment reflects how our chief operating decision maker (“CODM”), which is our chief executive officer, allocates resources and measures results. Although our CODM regularly uses gross profit for key operating decisions about allocating resources and assessing performance, we have concluded that consolidated net income (loss) is also used and is the measure of profit or loss required to be disclosed under the provisions of ASC 280 for our single operating segment. The CODM regularly reviews consolidated gross profit, net sales and consolidated net income in assessing performance and allocating resources. The expense information regularly provided to the CODM is substantially consistent with the expense captions presented in the consolidated statements of income and accompanying notes. The CODM's assessment of performance is predominantly performed during the Company’s annual budgeting and quarterly forecasting process where segment resourcing decisions, such as employee and capital, are made. The measure of segment assets reviewed by the CODM is total assets as reported in the Company's consolidated balance sheets. The Company conducts operations principally in Asia, the Americas, and Europe.
The table below sets forth net sales attributable to customers that individually accounted for 10% or more of consolidated net sales during the periods presented:
For the three months ended September 30,
For the nine months ended September 30,
Customer 1
60,976
44,594
151,035
124,133
Customer 2
72,443
51,880
177,963
134,744
Each customer that accounted for 10% or more of the Company's net sales is a broad-based distributor serving thousands of end customers. At September 30, 2026, two customers accounted for 16.9% and 10.6%, respectively, of the Company’s outstanding accounts receivable. At December 31, 2025, one customer accounted for approximately 16.3% of the Company's accounts receivable.
Disaggregation of Net Sales. The Company disaggregates net sales by sales channel and geographic area. Sales channels consist of direct sales to end customers and distribution sales to distributors ("Distributors"). Direct sales customers are customers that incorporate the Company's products into their manufacturing processes, while Distributors resell the Company's products to third-party customers.
The Company sells its products worldwide for use in the industrial, automotive, computing, consumer and communications end markets. Substantially all contracts with customers are fixed-price arrangements and are generally short-term in nature, ranging from several days to several months.
The tables below set forth net sales based on the location of the subsidiary producing the net sale:
-16-
For the Three Months Ended September 30, 2026
Asia
Americas
Europe
Consolidated
Total sales
552,144
371,296
70,076
993,516
Intercompany elimination
(240,524
(185,113
(35,292
(460,929
311,620
186,183
34,784
For the Three Months Ended September 30, 2025
442,991
298,683
63,003
804,677
(202,191
(171,276
(39,040
(412,507
240,800
127,407
23,963
As of and for the
Nine Months Ended September 30, 2026
1,463,469
983,371
205,583
2,652,423
(638,999
(530,754
(99,087
(1,268,840
824,470
452,617
106,496
526,170
75,261
86,586
1,763,909
1,066,497
260,486
Nine Months Ended September 30, 2025
1,192,521
837,343
180,888
2,210,752
(539,676
(474,653
(105,928
(1,120,257
652,845
362,690
74,960
492,175
68,893
96,345
657,413
1,608,545
599,627
261,619
2,469,791
-17-
The tables below set forth net sales for the Company disaggregated into geographic locations based on shipment destination and by type (direct sales or distributor sales):
For the Three Months Ended September 30,
Net Sales by Region
418,962
307,902
61,711
46,208
51,914
38,060
Total net sales
Net Sales by Type
Direct sales
174,093
132,074
Distributor sales
358,494
260,096
For the Nine Months Ended September 30,
1,083,830
852,170
173,782
136,328
125,971
101,997
486,865
383,903
896,718
706,592
The table below sets forth the location to where products were shipped, representing 10% or more of net sales in at least one of the periods shown below:
Location
China
269,297
170,565
Singapore
52,197
38,151
Taiwan
32,842
44,035
665,359
488,415
135,271
112,787
101,736
95,539
-18-
NOTE 9 – Debt
Borrowings outstanding as of September 30, 2026 and December 31, 2025 are set forth in the table below:
Current Amount
Interest Rate
Maturity
Short-term debt
Various indices plus margin
Various during next 12 months
Long-term debt
Notes payable to Bank of Taiwan
1,322
1,479
2-yr deposit rate floating plus 0.1148%
June 2033
4,705
4,770
2-yr deposit rate floating plus 0.082%
October 2027
Notes payable to CTBC Bank
3,180
TAIBOR 3M plus 0.5%
March 2028
April 2027
10,703
11,384
May 2028
Notes payable to E Sun Bank
50
95
1-M deposit rate floating plus 0.08%
July 2027
762
918
July 2030
58
99
1 M time deposit rate + 1.4%
Notes payable to Taishin Bank
78
258
2.82%
January 2027
314
January 2028
Notes payable to Chang Hwa Bank
31
32
2.22%
November 2030
47
48
December 2030
223
January 2031
Notes payable to China Everbright Bank
164
2.70%
September 2031
Convertible Senior Notes
375,000
0%
August 2031
Total long-term debt
393,548
25,666
Less: Current portion of long-term debt
(1,571
(1,442
Less: Unamortized debt-issuance costs
(10,068
Total long-term debt, net of current portion
Our Asia subsidiaries maintain credit facilities with several financial institutions through our foreign entities worldwide totaling $150.0 million. Other than two Taiwanese credit facilities that are collateralized by assets, our foreign credit lines are unsecured, uncommitted and contain no restrictive covenants. These credit facilities bear interest at the Taipei Interbank Offered Rate (or similar indices) plus a specified margin. Interest payments are due monthly on outstanding amounts under the credit lines. The unused and available credit under the various facilities as of September 30, 2026, was approximately $128.5 million, net of $21.0 million advanced under our foreign credit lines and $0.4 million credit used for import and export guarantee.
The Company maintains a long-term credit facility (“Credit Agreement”). The Credit Agreement consists of a Revolving Credit Facility (“Revolving Credit Facility”) in the amount of $225.0 million, including a swing line sublimit equal to the lesser of $50.0 million and the Revolving Credit Facility, a letter of credit sublimit equal to the lesser of $100.0 million and the Revolving Credit Facility, and an alternative currency sublimit equal to the lesser of $40.0 million and the Revolving Credit Facility. The Company has the option to increase the Revolving Credit Facility and/or incur Incremental Term Loans in an aggregate principal amount of up to $350.0 million.
On August 12, 2026, the Company entered into Amendment No. 1 to the Credit Agreement (the “Amendment”). The Amendment, among other things, (i) extended the maturity date of the Revolving Credit Facility from May 26, 2028 to August 12, 2031, (ii) revised the pricing grid applicable to outstanding borrowings and unused commitments, (iii) permitted the issuance of the Convertible Senior Notes discussed below, and (iv) amended certain financial and negative covenants. Borrowings under the Revolving Credit Facility bear interest at variable rates based on applicable benchmark rates plus an applicable margin determined under the Credit Agreement.
The obligations under the Credit Agreement are secured by a lien on substantially all assets of the Company and certain of its subsidiaries. At September 30, 2026, there were no borrowings or letters of credit outstanding under the Revolving Credit Facility, and the full $225.0 million remained available for borrowing. The Company was in compliance with all financial and non-financial covenants under the Credit Agreement as of September 30, 2026.
In connection with the Amendment, the Company incurred $1.3 million of incremental fees and other costs. The Company accounted for the Amendment in accordance with the applicable debt modification guidance. Accordingly, the incremental fees and other costs incurred in connection with the Amendment were capitalized as debt issuance costs and are being amortized over the remaining term of the amended Revolving Credit Facility.
-19-
On August 18, 2026, the Company completed a private offering of $375.0 million aggregate principal amount of 0.00% Convertible Senior Notes due 2031 (the "Convertible Senior Notes"), including the exercise in full of the initial purchasers' option to purchase an additional $50.0 million aggregate principal amount. The Convertible Senior Notes were issued pursuant to an Indenture, dated August 18, 2026 (the “Indenture”), between the Company and U.S. Bank Trust Company, National Association, as trustee. The Convertible Senior Notes are senior unsecured obligations of the Company and mature on August 15, 2031, unless earlier converted, redeemed, or repurchased. The Convertible Senior Notes do not bear regular interest, and the principal amount does not accrete. Special interest may accrue under certain circumstances as provided in the Indenture.
The initial conversion rate of the Convertible Senior Notes is 6.8594 shares of the Company's common stock per $1,000 principal amount of Convertible Senior Notes, which represents an initial conversion price of approximately $145.79 per share. As of September 30, 2026, the conversion rate had not been adjusted.
Prior to May 15, 2031, holders may convert their Convertible Senior Notes only upon the occurrence of certain events and during specified periods as set forth in the Indenture. On or after May 15, 2031, holders may convert the Convertible Senior Notes at any time until the close of business on the second scheduled trading day immediately preceding the maturity date. Upon conversion, the Company is required to settle the principal amount of the Convertible Senior Notes in cash and may settle any conversion value in excess of the principal amount in cash, shares of the Company's common stock, or a combination thereof, at its election, in accordance with the terms of the Indenture.
The conversion rate is subject to adjustment upon the occurrence of certain events in accordance with the terms of the Indenture. In addition, following certain corporate events that occur prior to the maturity date, or if the Company issues a notice of redemption, the Company may be required to increase the conversion rate for holders who elect to convert their Convertible Senior Notes in connection with such events.
The Convertible Senior Notes are not redeemable by the Company prior to August 20, 2029. On or after August 20, 2029, and prior to the 31st scheduled trading day immediately preceding maturity, the Company may redeem all or a portion of the Convertible Senior Notes for cash, subject to certain conditions, including that the last reported sale price of the Company's common stock is at least 130% of the then-applicable conversion price for a specified period. The redemption price equals 100% of the principal amount of the Convertible Senior Notes being redeemed, plus any accrued and unpaid special interest to, but excluding, the redemption date.
The Company received net proceeds of approximately $364.8 million from the offering after deducting the initial purchasers' discounts, commissions and offering expenses and prior to giving effect to the cost of the Capped Call Transactions described below. The Company used approximately $21.9 million of the net proceeds to pay premiums for the Capped Call Transactions and approximately $35.0 million to repurchase approximately 0.4 million shares of its common stock. The Company expects to use the remaining net proceeds for general corporate purposes, including potential future acquisitions.
The Convertible Senior Notes are accounted for as a single liability measured at amortized cost. Debt issuance costs associated with the Convertible Senior Notes are presented as a reduction of the carrying amount of the Convertible Senior Notes and are amortized to interest expense over the contractual term of the Convertible Senior Notes using the effective interest method. As of September 30, 2026, the carrying amount of the Convertible Senior Notes was $364.9 million, consisting of $375.0 million in principal amount, net of $10.1 million of unamortized debt issuance costs. For the three and nine months ended September 30, 2026, the Company recognized $0.2 million of interest expense related to the amortization of debt issuance costs. The effective interest rate on the Convertible Senior Notes was approximately 0.55%.
Other Notes Payable
In addition to our U.S. Credit Agreement, our 53% owned subsidiary, ERIS, had long-term debt of $17.5 million and $25.0 million, at September 30, 2026 and December 31, 2025, respectively, from local Taiwan banks. The outstanding ERIS debt matures in various periods from 2027 through 2033.
Capped Call Transactions
In connection with the issuance of the Convertible Senior Notes, the Company entered into privately negotiated Capped Call Transactions (the “Capped Call Transactions”) with certain financial institutions. The Capped Call Transactions are expected generally to reduce the potential dilution to the Company's common stock upon any conversion of the Convertible Senior Notes and/or offset any cash payments the Company is required to make in excess of the principal amount of Convertible Senior Notes, as the case may be. The Capped Call Transactions have an initial strike price of approximately $145.79 per share, which corresponds to the initial conversion price of the Convertible Senior Notes, and an initial cap price of $194.38 per share, subject to customary adjustments under the terms of the Capped Call Transactions.
The Capped Call Transactions cover, subject to customary adjustments, the number of shares of the Company's common stock initially underlying the Convertible Senior Notes. The Capped Call Transactions are generally expected to reduce potential dilution to the Company's common stock upon conversion of the Convertible Senior Notes and/or offset any cash payments the Company is required
-20-
to make in excess of the principal amount of converted Convertible Senior Notes, subject to the cap. The Capped Call Transactions are separate transactions entered into by the Company and are not part of the terms of the Convertible Senior Notes. Holders of the Convertible Senior Notes do not have any rights with respect to the Capped Call Transactions.
The Company paid premiums of approximately $21.9 million for the Capped Call Transactions, which were recorded within stockholders' equity as a reduction to additional paid-in capital, net of the related deferred tax benefit. The Capped Call Transactions are generally expected to reduce dilution resulting from conversion of the Convertible Senior Notes to the extent that the market price of the Company's common stock exceeds the initial conversion price of the Convertible Senior Notes, subject to the cap price. Because the Capped Call Transactions are classified in stockholders' equity, they are not subsequently remeasured at fair value.
NOTE 10 – Commitments and Contingencies
Purchase Commitments. We have entered into non-cancelable purchase contracts for capital expenditures, primarily for manufacturing equipment, for approximately $98.8 million at September 30, 2026. As of September 30, 2026, we also had a commitment to purchase approximately $41.9 million of wafers to be used in our manufacturing process. These wafer purchases are scheduled to occur through 2031.
Contingencies. From time to time, we are involved in various legal proceedings that arise in the normal course of business. While we intend to defend any lawsuit vigorously, we presently believe that the ultimate outcome of any pending legal proceeding will not have any material adverse effect on our consolidated financial position, cash flows, or operating results. However, litigation is subject to inherent uncertainties, and unfavorable rulings could occur. An unfavorable ruling could include monetary damages, which could impact our business and operating results for the period in which the ruling occurs and future periods. Based on information available, we evaluate the likelihood of potential outcomes of all pending disputes. We record an appropriate liability when the amount of any liability associated with a pending dispute is deemed probable and reasonably estimable. In addition, we do not accrue estimated legal fees and other directly related costs as they are expensed as incurred. The Company is not currently a party to any pending litigation that we consider material.
NOTE 11 – Derivative Financial Instruments
We use derivative instruments to manage risks related to foreign currencies, interest rates, commodity price management, and the net investment risk in our foreign subsidiaries. Our objectives for holding derivatives include reducing, eliminating, and efficiently managing the economic impact of these exposures as effectively as possible. Our derivative programs include strategies that both qualify and do not qualify for hedge accounting treatment. The Company does not enter into derivative contracts for speculative purposes.
Commodity Price Risk Management. The Company purchases gold that is used in the manufacturing of connectors, electronic components, and other products. Gold prices are subject to significant market volatility, which can affect the Company's production costs and operating margins.
To manage a portion of its exposure to fluctuations in gold prices, the Company enters into commodity swap contracts. Our gold derivative contracts are designated and accounted for as cash flow hedges of forecasted gold purchases under ASC 815. As of September 30, 2026 and December 31, 2025, we had $6.8 million and zero, respectively, of outstanding commodity swaps. At September 30, 2026, the Company had outstanding commodity swap contracts covering approximately 1,398 troy ounces of forecasted gold purchases through March 31, 2027. As of September 30, 2026. the pre-tax amount deferred in accumulated other comprehensive income that is expected to be reclassified into cost of goods sold within the next twelve months is $1.4 million.
Hedges of Foreign Currency Risk. We are exposed to fluctuations in various foreign currencies relative to our functional currencies. We use foreign currency forward contracts to manage this exposure. As of September 30, 2026 and December 31, 2025, we had $415.3 million and $345.2 million, respectively, of outstanding foreign currency forward contracts that are intended to preserve the economic value of foreign currency-denominated monetary assets and liabilities; these instruments are not designated for hedge accounting treatment in accordance with Accounting Standards Codification (“ASC”) No. 815. Included in the derivative asset and liability balances as of September 30, 2026 and December 31, 2025 were approximately $1.9 million and $1.3 million, respectively, related to foreign currency forward contracts that had settled as of the balance sheet date but for which cash settlement with the counterparties had not yet occurred. These amounts represent settlement receivables or payables and do not relate to outstanding derivative positions.
-21-
Hedges of Interest Rate and Net Investment Risk. The Company’s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish these objectives, the Company primarily uses interest rate swaps, including interest rate collars, as part of its interest rate risk management strategy. Interest rate swaps designated as cash flow hedges involve the receipt of variable amounts from a counterparty in exchange for the Company making fixed-rate payments over the life of the contracts without exchange of the underlying notional amount. The Company makes use of cross-currency swaps and foreign-currency forward contracts to decrease the foreign exchange risk inherent in the Company’s investment in some of its foreign subsidiaries.
The table below sets forth the fair value of the Company’s derivative financial instruments, which are Level 2 instruments in the fair-value hierarchy, as well as their classification on our condensed consolidated balance sheets as of September 30, 2026 and December 31, 2025:
Fair Value
Other Current or Non-Current Assets
Other Current or Non-Current Liabilities
Derivatives with hedge designations
Collared forwards
964
2,558
884
Derivatives without hedge designations
Foreign exchange forwards
The table below sets forth the effect of the Company’s derivative financial instruments on the Consolidated Statements of Comprehensive Income for the three and nine months ended September 30, 2026 and 2025:
Derivative Instruments
Amount of Gain or (Loss) Recognized in OCI on Derivative
Location of Gain or (Loss) Recognized in Income on Derivative (Ineffective Portion Excluded from
Amount of Gain or (Loss) Recognized in Income on Derivative (Ineffective Portion and Amount Excluded from Effectiveness Testing)
Designated as
Effectiveness
Hedging Instruments
Testing)
(649
17,491
1,800
6,176
266
(162
N/A
(2,144
8,418
15,484
(1,522
During the three months ended September 30, 2026 and 2025, the Company recognized gains of approximately $1.8 million and $6.2 million, respectively, related to collared forward contracts in interest income. During the three months ended September 30, 2026, the Company recognized losses of approximately $0.2 million related to commodity swap contracts in cost of goods sold, increasing cost of goods sold expense by the same amount. No amounts related to commodity swap contracts were recognized in earnings during the three months ended September 30, 2025.
During the nine months ended September 30, 2026 and 2025, the Company recognized gains of approximately $8.4 million and $15.5 million, respectively, related to collared forward contracts in interest income. During the nine months ended September 30, 2026, the Company recognized losses of approximately $0.2 million related to commodity swap contracts in cost of goods sold, increasing cost of goods sold expense by the same amount. No amounts related to commodity swap contracts were recognized in earnings during the nine months ended September 30, 2025.
NOTE 12 – Employee Benefit Plans
We maintain a Non-Qualified Deferred Compensation Plan (the “Deferred Compensation Plan”) for executive officers, key employees, and members of the Board of Directors. The Deferred Compensation Plan allows eligible participants to defer the receipt of eligible compensation, including equity awards, until designated future dates. We offset our obligations under the Deferred Compensation Plan primarily by investing in the actual underlying investments. At September 30, 2026 and December 31, 2025, these investments totaled approximately $21.6 million and $20.0 million, respectively.
NOTE 13 – Related Parties
We conduct business with the following related parties: Keylink International (B.V.I.) Inc. and its subsidiaries and affiliates (“Keylink”), Nuvoton Technology Corporation (“Nuvoton”), Jiyuan Crystal Photoelectric Frequency Technology Ltd. (“JCP”), Atlas Magnetics, Co. (“Atlas”), and ATX Semiconductor SDN (“ATX”).
-22-
Keylink is a 5% joint venture partner in our Shanghai assembly and test facilities. We sell products to, and purchase inventory from, companies owned by Keylink. In addition, our subsidiaries in China lease their manufacturing facilities in Shanghai from, and subcontract a portion of our manufacturing process (metal plating and environmental services) to Keylink. We also pay a consulting fee to Keylink.
Warren Chen, a member of the Company’s board of directors, serves as a member of the Nuvoton board of directors. In the nine months ended September 30, 2026, we purchased approximately $1.4 million of wafers from Nuvoton under an agreement that ended in the second quarter of 2026. We consider our relationship with Nuvoton to be mutually beneficial, and plan to continue our strategic alliance with Nuvoton.
JCP is a frequency control product manufacturing company from which we purchase material and in which we have made an equity investment that we account for using the equity method of accounting.
Atlas is an early stage privately held fabless wafer design company in which the Company holds a majority interest. The Company determined that Atlas is a variable interest entity (“VIE”), and the Company does not have the power to direct the activities that most significantly impact Atlas. The Company has therefore determined that the Company is not the primary beneficiary. Consequently, we do not consolidate the assets and liabilities of Atlas in the Company’s financial statements. For additional information related to Atlas see Note 14 - Equity Investments - Unconsolidated VIE, below.
In June 2025, the Company entered into a Joint Venture Agreement to acquire a 43% interest and joint control of ATX, a Malaysian private limited liability company, with the purpose of building synergies related to testing and packaging. ATX is a related party for the Company.
The table below sets forth the revenues and expenses with our related parties:
Keylink:
(37
87
(10
Purchases
339
6
804
205
Plating, rental, and consulting expense
4,104
3,438
11,581
9,966
Nuvoton:
27
56
1,158
2,218
6,421
4,561
JCP:
105
Atlas:
1,397
2,055
5,750
8,793
ATX:
224
520
The table below sets forth accounts receivable from, and accounts payable to, our related parties:
Accounts receivable
31,974
25,415
35,488
27,837
9
1,011
1,131
721
73
12
NOTE 14 - Equity Investments
The Company maintains equity investments in companies which are accounted for under the measurement alternative described in ASC 321-10-35-2 for equity securities that lack readily determinable fair values. As of September 30, 2026 and December 31, 2025, the Company had $97.7 million and $97.4 million, respectively, of investments accounted for under the measurement alternative. During
-23-
the nine months ended September 30, 2026, the Company recorded $16.4 million of non-cash mark-to-market adjustments related to the value of a previously made equity investments. During the nine months ended September 30, 2026 and 2025, the Company recorded $1.2 million and $5.8 million, respectively, of non-cash impairment charges related to the decreases in value of a previously made equity investments.
Unconsolidated VIE
During July 2021, the Company acquired an interest in Atlas, an early stage privately held fabless wafer design company located in the western United States. The Company’s initial investment in July 2021 was $10.0 million of preferred stock and a $5.0 million convertible promissory note. In April 2023, the Company acquired an additional interest in Atlas by purchasing $13.9 million of preferred stock and the Company’s previously held convertible note converted to $5.2 million of preferred stock. In June 2025, the Company acquired an additional interest in Atlas by purchasing $12.3 million of preferred stock. In connection with the additional investment in Atlas in June 2025, the Company recorded an upward mark-to-market adjustment of $33.3 million to adjust the value of the investment. The primary purpose for providing the additional investments in Atlas was to provide for continued access to developing technology with potential future benefit to the Company. At September 30, 2026, the Company continues to own more than 50% of Atlas. The Company determined that Atlas is a VIE and a related party. While the Company does own more than 50% of Atlas, according to the voting agreement governing the transaction, the Company does not have the power to control the board of directors or direct the activities that most significantly impact Atlas, including:
The hiring and firing of officers (i.e., CEO, CFO, etc.) – The hiring and firing of personnel responsible for making the key daily decisions and implementing the strategic operating direction will determine the success the Company has in their initiatives, thereby affecting the economic performance;
Determining the business plan and budget, including incurring additional indebtedness or issuing additional equity interests – As Atlas is thinly capitalized, the decisions around when and how to obtain cash will influence whether Atlas can continue operating; and
Determining the strategic operating direction of Atlas – The decisions made around the significant operating direction of Atlas will significantly impact the overall performance of the Company by determining where and how Atlas limited capital is spent without having significant revenues to keep the Company operating.
As the Company is not the primary beneficiary of Atlas, the Company did not consolidate the assets and liabilities of Atlas in our financial statements and instead accounts for the investment under the measurement alternative described in ASC 321-10-35-2 for equity securities that lack readily determinable fair value. As such, the Company’s investment is measured at cost less impairment, and adjusted to fair value if there are any observable price changes for identical or similar investment of the same issuer.
Atlas is funded through debt and equity. The Company's maximum exposure to loss is limited to its investment in Atlas and notes receivable and accrued interest owed to the Company from Atlas. The following is a summary of the Company’s holdings in Atlas, a VIE, in which we are not the primary beneficiary:
VIE total assets
33,810
39,620
VIE total liabilities
11,363
10,659
Diodes' equity in VIE
90,035
Diodes' note receivable from VIE
9,000
Diodes' interest receivable from VIE
965
628
Diodes' maximum exposure to loss
100,000
99,663
ATX Semiconductor SDN
In June 2025, the Company entered into a joint venture agreement with Global Advanced Packaging Test Limited to acquire a 43% interest in and joint control of ATX, a Malaysian private limited liability company, with the purpose of building synergies related to testing and packaging. The ATX joint venture meets the accounting definition of a joint venture where neither party has unilateral control of the entity and both parties have joint control over the decision-making process in the entity. As such, the Company uses the equity method to account for its share of the investment in ATX. The carrying value of the equity investment is $19.3 million as of September 30, 2026. The Company recorded and will continue to record equity method earnings of the joint venture on a 3-month lag.
Note 15 - Acquisitions and dispositions
ElevATE Semiconductor Acquisition
On August 27, 2026, (the “Acquisition Date”) the Company closed its acquisition of 100% of the outstanding equity interests of ElevATE, a developer of highly integrated, low-power analog and mixed-signal semiconductor solutions for semiconductor test
-24-
applications. The acquisition expands Diodes' analog and mixed-signal product portfolio and strengthens the Company's position in attractive, high-growth end markets driven by increasing semiconductor complexity and test intensity.
The total aggregate purchase price was $267.1 million and total net consideration was $238.7 million after adjusting for cash acquired. The purchase price was funded with our available cash. The acquisition agreement provides for additional contingent payments of up to $50.0 million upon the achievement of specified revenue and gross margin targets. The acquisition-date fair value of the contingent consideration was approximately $4.9 million, determined using a Monte Carlo simulation based on the probability and timing of achieving the applicable revenue thresholds. The contingent consideration was recorded in other long-term liabilities and is remeasured at fair value at each subsequent reporting date, as a level 3 fair value measurement, with changes in fair value recognized in earnings. As of September 30, 2026, the fair value of the contingent consideration liability was $4.9 million.
The table below sets forth the estimated fair value of the purchase consideration:
Cash paid to acquire outstanding equity interests of ElevATE
262,274
Fair value of contingent consideration
Transaction costs paid on seller's behalf
(4
Purchase consideration
267,146
The acquisition was accounted for as a business combination in accordance with ASC 805, Business Combinations. Accordingly, the assets acquired and liabilities assumed were recognized at their estimated acquisition-date fair values, with the excess of consideration transferred over the fair value of identifiable net assets acquired recognized as goodwill. The following table summarizes the preliminary purchase price allocation:
Estimated fair value of assets acquired:
28,477
4,350
28,000
Prepaid expenses and other current assets
227
Property, plant, and equipment
4,337
Intangible assets
199,000
655
Total assets acquired
265,046
Estimated fair value of liabilities assumed:
781
32,199
416
45,193
Total liabilities assumed
78,589
Total identifiable net assets
186,457
The excess of the total equity value of ElevATE over net assets acquired was recorded as goodwill. The goodwill is primarily attributable to the synergies expected to arise from the integration of ElevATE's technologies and product portfolio with the Company's existing operations, as well as the value of the assembled workforce. None of the goodwill is expected to be deductible for tax purposes.
The intangible assets acquired as a result of the acquisition consisted of developed technologies, in-process research & development (“IPR&D”), customer contracts and related relationships, and trademarks, the finite-lived assets will be amortized over the estimated useful life. The approximate fair values of the developed technologies, IPR&D, customer contracts and related relationships and trademarks is $64.0 million, $15.0 million, $115.0 million and $5.0 million, respectively. The fair value of developed technologies, IPR&D, and trademarks were valued using a Relief-from-royalty (“RfR”) Method. The RfR method estimates the fair value of an intangible asset by calculating the present value of the hypothetical royalty payments that would have been required if the Company did not own the asset and instead licensed it from a third party. The fair value of customer contracts and related relationships were valued using a Multi-Period Excess Earnings method. The Multi-Period Excess Earning method model estimates revenues and cash flows derived from the asset and then deductions portions of the cash flow that can be attributed to supporting assets.
Finite-lived intangible assets are amortized over their estimated useful lives, which range from 11 to 23 years. Estimated future amortization expense is approximately $3.5 million in 2026 and $13.9 million in each of 2027, 2028, 2029, 2030, and 2031. Acquired IPR&D assets are classified as indefinite-lived intangible assets and are not amortized until the underlying projects are completed, at
-25-
which time the assets are evaluated for their estimated useful lives and amortization begins. If an IPR&D project is abandoned, the related asset is evaluated for impairment. The Company incurred approximately $2.0 million of acquisition related expenses, which primarily consisted of transaction fees and legal, accounting and other professional services that are included in the accompanying unaudited condensed consolidated statements of operations within Selling, general, and administrative expenses. These costs were expensed as incurred.
The purchase price allocation is preliminary and subject to adjustment during the measurement period, which will not exceed one year from the acquisition date. The Company is continuing to evaluate the acquisition-date fair values of certain assets acquired and liabilities assumed, including intangible assets, inventory, and the related income tax effects. The preliminary amounts may be adjusted as additional information regarding facts and circumstances existing as of the Acquisition Date becomes available. Any qualifying measurement-period adjustments will be recognized in the reporting period in which the adjustments are determined, with the corresponding effect generally recorded to goodwill.
Unaudited Pro Forma Financial Information
The amounts of revenue and earnings of ElevATE included in the Company's consolidated statement of operations from the acquisition date to the period ending September 30, 2026 are as follows (in thousands):
August 28, 2026
1,925
219
The following unaudited pro forma summary presents consolidated information of the Company as if the acquisition and consolidation of ElevATE had occurred on January 1, 2025:
Three months ended
September 30, 2025
543,238
396,484
1,404,422
1,109,971
37,417
9,451
95,278
43,436
The unaudited pro forma consolidated results of operations do not purport to be indicative of the results that would have been obtained if the above acquisition had actually occurred as of the dates indicated or of those results that may be obtained in the future.
The unaudited pro forma consolidated results for the three months and nine months ended September 30, 2026, include adjustments that result in an increase to amortization expense of $3.5 million and $10.4 million, respectively, an additional $0.6 million and $1.7 million in interest expense, respectively, and a reduction of $0.3 million and $0.4 million of share based compensation expense, respectively. The income tax impact of these adjustments was $0.8 million and $2.5 million for the three and nine months ended September 30, 2026, respectively.
The unaudited pro forma consolidated results for the three months and nine months ended September 30, 2025, include adjustments that result in an increase to amortization expense of $3.5 million and $10.4 million, respectively, an additional $0.6 million and $1.7 million in interest expense, respectively, a reduction of $0.1 million and $0.4 million of share based compensation expense, respectively, and an additional $2.4 million and $9.2 million of cost of goods sold, respectively. The income tax impact of these adjustments was $1.3 million and $4.4 million for the three and nine months ended September 30, 2025, respectively.
These unaudited pro forma consolidated results of operations were derived, in part, from the historical consolidated financial statements of ElevATE and other available information and assumptions believed to be reasonable under the circumstances.
TF Semiconductor Solutions, Inc. Agreement and Plan of Merger
During the three months ended September 30, 2026, the Company received 29,249 shares of Microchip Technology Incorporated (“MCHP”) common stock as additional consideration related to the 2025 sale of its investment in TF Semiconductor Solutions, Inc (“TFSS”). The shares were recorded at fair value upon receipt. The Company sold 13,025 shares, receiving approximately $1.0 million, during the three months ended September 30, 2026 and retained the remaining shares as of September 30, 2026. The Company recorded deferred consideration of approximately $1.3 million in connection with the disposition, representing the estimated fair value of MCHP shares expected to be received from the indemnity fund. Upon execution of a settlement agreement with MCHP with respect to purchase price and indemnification matters, the final amount of consideration became fixed. As a result, the Company recognized an increase in the value of the previously recorded share consideration from approximately $1.3 million to $2.4 million and the $2.8 million earnout
-26-
cash consideration that had not previously met the recognition criteria due to uncertainty surrounding the contingency. The aggregate gain recognized during the three months ended September 30, 2026 was approximately $3.8 million.
-27-
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.
Except for the historical information contained herein, the matters addressed in this Item 2 constitute “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and as identified under the heading “Cautionary Statement for Purposes of the “Safe Harbor” Provision of the Private Securities Litigation Reform Act of 1995” herein. Such forward-looking statements are subject to a variety of risks and uncertainties, including those discussed in the subsection “Risk Factors” set forth in Part II, Item 1A of this Quarterly Report on Form 10-Q and Part I, Item 1A of our most recent Annual Report on Form 10-K, and similar discussions elsewhere in this Quarterly Report on Form 10-Q and in other reports we file with the SEC from time to time, that could cause actual results to differ materially from those anticipated by our management. The Private Securities Litigation Reform Act of 1995 (the “PSLRA”) provides certain “safe harbor” provisions for forward-looking statements. All forward-looking statements made in this Quarterly Report on Form 10-Q are made pursuant to the PSLRA. We undertake no obligation to publicly release the results of any revisions to our forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unexpected events. Unless the context otherwise requires, the words “Diodes,” the “Company,” “we,” “us,” and “our” refer to Diodes Incorporated and its subsidiaries. Dollar amounts and share amounts are presented in thousands, except per share amounts, unless otherwise noted.
This management’s discussion should be read in conjunction with the management’s discussion included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2025 (“Form 10-K”), previously filed with Securities and Exchange Commission (“SEC”) on February 10, 2026.
Overview
The Company’s diverse product portfolio includes diodes, rectifiers, transistors, MOSFETs, SiC devices, protection devices, logic and interface solutions, amplifiers and comparators, sensors, isolation products, pin electronics PE), device power supply (DPS), and power management devices. Our power management devices include AC-DC converters, DC-DC switching, linear regulators, LED drivers, and voltage references. Our solutions also extend to timing and connectivity products, including clock ICs, crystal oscillators, PCIe and multi-protocol switches, and signal integrity solutions for high-speed applications.
Summary for the three months ended September 30, 2026
As of September 30, 2026, our cash, cash equivalents, and short-term investments were $574.9 million, and we had access to unused borrowing capacity of $225.0 million under the revolving portion of our U.S. Credit Agreement. We believe our liquidity and our borrowing capacity will allow us to cover our cash needs for working capital, capital expenditures, and acquisitions for at least the next 12 months.
On August 18, 2026, we issued $375.0 million aggregate principal amount of 0.00% Convertible Senior Notes due 2031 (the "Convertible Senior Notes"), including the exercise in full of the initial purchasers' option to purchase an additional $50.0 million aggregate principal amount. The Convertible Senior Notes were issued pursuant to an Indenture, dated August 18, 2026 (the “Indenture”), between the Company and U.S. Bank Trust Company, National Association, as trustee. The Convertible Senior Notes are senior unsecured obligations of the Company and mature on August 15, 2031, unless earlier converted, redeemed, or repurchased. The Convertible Senior Notes do not bear regular interest, and the principal amount does not accrete. Special interest may accrue under
-28-
certain circumstances as provided in the Indenture. Also in August 2026, in connection with the pricing of the Convertible Senior Notes and the exercise by the initial purchasers of their option in full to purchase additional notes, we entered into the Capped Call Transactions with several financial institutions, including one or more of the initial purchasers and/or their respective affiliates.
On August 27, 2026, the Company completed its previously announced all cash acquisition of ElevATE Semiconductor, Inc. ("ElevATE"), a fabless semiconductor company based in San Diego, California that specializes in the development of integrated circuits for the automated test equipment industry. The aggregate merger consideration of $267.1 million was based on a $250.0 million base purchase price, subject to customary adjustments for cash, indebtedness, transaction costs, taxes, and net working capital. In addition, the merger agreement provides for potential earnout payments of up to $50.0 million in the aggregate based on the achievement of specified post-closing revenue and gross margin thresholds for calendar years 2027 through 2030. The ElevATE acquisition advances the Company’s portfolio and content expansion initiatives to capitalize on the growing demand for semiconductor test solutions.
The Company’s third quarter revenue reached record levels coupled with an over 500-basis point year-over-year increase in gross margin to 36.1%, with global point of sales reaching record level in the quarter. The Company’s over 19% sequential revenue growth was primarily driven by continued market share gains in the automotive market, improving demand across broad industrial applications, and continued momentum in the artificial intelligence ecosystem. Underpinning this growth is the benefit of the targeted investments we made in capacity expansion over the past year coming online.
Results of operations for the three months ended September 30, 2026 and 2025
The table below sets forth the condensed consolidated statement of operations line items as a percentage of net sales:
100
(64
(69
(24
2
(3
(0
4
The following table and discussion explains in greater detail our consolidated operating results and financial condition for the three months ended September 30, 2026, compared to the three months ended September 30, 2025. This discussion should be read in conjunction with the condensed consolidated financial statements and notes thereto appearing elsewhere in this Quarterly Report on Form 10-Q.
Increase/(Decrease)
% Change
140,417
35.8
68,440
25.2
71,977
59.7
20,136
18.5
(3,689
(43.5
%)
310
61.6
(351
10.5
(8,432
(352.7
(80
(9.5
10,536
296.4
(1,937
448.4
29,434
206.1
Net sales increased approximately $140.4 million, or 35.8%, for the three months ended September 30, 2026, compared to the same period last year, primarily driven by continued market share gains in the automotive market, improving demand across broad industrial applications, and continued momentum in the artificial intelligence ecosystem. Underpinning this growth is the benefit of the
-29-
targeted investments we made in capacity expansion over the past year coming online. During the three months ended September 30, 2026, weighted-average sales price increased 13.5% and volume increased 19.7%, when compared to the same period in 2025.
The table below sets forth our product revenue as a percentage of total product revenue by end-user market for the three months ended September 30, 2026 and 2025:
Industrial
24%
22%
Automotive
19%
Computing
27%
28%
Consumer
17%
18%
Communications
10%
13%
For the three months ended September 30, 2026, gross profit increased approximately 59.7% when compared to the same period last year primarily due to higher net sales. Gross profit margin for the three months ended September 30, 2026 and 2025 was 36.1% and 30.7%, respectively.
Operating expenses for the three months ended September 30, 2026, increased $20.1 million when compared to the three months ended September 30, 2025. Operating expenses as a percentage of net sales were 24.2% and 27.8% for the three months ended September 30, 2026 and 2025, respectively. SG&A increased approximately $19.7 million as compared to the same period last year reflecting an increase in salaries and wages of $7.3 million, increased selling expenses of approximately $6.3 million, increased professional services of approximately $2.5 million, and increased freight and duty expense of $1.6 million. SG&A, as a percentage of net sales, was 15.1% and 15.4% for the three months ended September 30, 2026 and 2025 respectively. For the three months ended September 30, 2026, research and development expenses (“R&D”) was flat when compared to the three months ended September 30, 2025. R&D, as a percentage of net sales, was 8.2% and 10.7% for the three months ended September 30, 2026 and 2025, respectively.
Interest income decreased $3.7 million, or 43.5%, for the three months ended September 30, 2026, compared to the same period last year, reflecting less interest income received in the Company’s derivative hedging instruments. Interest expense increased due primarily to amortization of debt issuance costs associated with the Convertible Senior Notes, for the three months ended September 30, 2026, compared to the same period last year. During the three months ended September 30, 2026, the Company recognized $6.0 million in unrealized losses on investments for mark-to-market adjustments.
We recognized income tax expense of approximately $14.1 million and $3.6 million for the three months ended September 30, 2026 and 2025, respectively. The increase in income taxes for 2026 compared to 2025 is primarily attributable to the change in pre-tax earnings during the comparable periods, including the geographical mix of pre-tax income and loss across tax jurisdictions.
Results of operations for the nine months ended September 30, 2026 and 2025
(66
34
(25
(29
0
(2
5
The following table and discussion explains in greater detail our consolidated operating results and financial condition for the nine months ended September 30, 2026, compared to the nine months ended September 30, 2025. This discussion should be read in
-30-
conjunction with the condensed consolidated financial statements and notes thereto appearing elsewhere in this Quarterly Report on Form 10-Q.
293,088
26.9
164,771
22.0
128,317
37.7
34,106
10.7
(5,533
(25.9
353
23.9
(2,572
(11,577
(41.3
4,568
(78.5
(9,889
(72.0
(499
(27.3
12,300
97.3
(6,656
1600.0
49,383
88.3
Net sales increased approximately $293.1 million, or 26.9%, for the nine months ended September 30, 2026, compared to the same period last year. During the nine months ended September 30, 2026, weighted-average sales price increased 1.7% and volume increased 24.7%, when compared to the same period in 2025.
The table below sets forth our product revenue as a percentage of total product revenue by end-user market for the nine months ended September 30, 2026 and 2025:
23%
21%
11%
For the nine months ended September 30, 2026, gross profit increased approximately 37.7% when compared to the same period last year primarily due to higher net sales. Gross profit margin for the nine months ended September 30, 2026 and 2025 was 33.9% and 31.2%, respectively.
Operating expenses for the nine months ended September 30, 2026, increased $34.1 million when compared to the nine months ended September 30, 2025. Operating expenses as a percentage of net sales were 25.5% and 29.2% for the nine months ended September 30, 2026 and 2025, respectively. SG&A increased approximately $35.6 million as compared to the same period last year reflecting an increase in salaries and wages of $19.1 million, an increase in selling expense of $5.9 million, an increase in freight and duty expense of $4.5 million, an increase in operating expense of $2.8 million, and an increase in consulting and legal expense of $2.5 million, and SG&A, as a percentage of net sales, was 15.5% and 16.4% for the nine months ended September 30, 2026 and 2025, respectively.
R&D increased approximately $4.1 million when compared to the nine months ended September 30, 2025 due to increased R&D expenses related to salaries and wages of $7.8 million, an increase in depreciation and amortization of $4.4 million, and an increase in selling expenses of $1.0 million. These increases in R&D expenses were partially offset by decreases in R&D marketing expense of $6.9 million and decreases in R&D operating expenses of $2.0 million. R&D, as a percentage of net sales, was 9.0% and 11.1% for the nine months ended September 30, 2026 and 2025, respectively.
Interest income decreased $5.5 million, or 25.9%, for the nine months ended September 30, 2026, compared to the same period last year, reflecting lower amounts of interest income received in the Company’s derivative hedging instruments. Interest expense increased due primarily to amortization of debt issuance costs associated with the Convertible Senior Notes, for the nine months ended September 30, 2026, compared to the same period last year. During the nine months ended September 30, 2026, the Company recognized an impairment loss on an equity investment of $1.2 million, due to a decline in the value of the investment. During the nine months ended September 30, 2026, the Company recognized upward fair value adjustments of $16.4 million related to long-term investments.
-31-
We recognized income tax expense of approximately $24.9 million and $12.6 million for the nine months ended September 30, 2026 and 2025, respectively. The increase in income taxes for 2026 compared to 2025 was primarily attributable to an increase in pre-tax earnings.
Financial Condition
Liquidity and Capital Resources
Our primary sources of liquidity consist of cash and cash equivalents, cash generated from operations, availability under our Revolving Credit Facility, and access to capital markets. Our primary uses of cash include working capital requirements, capital expenditures, strategic acquisitions, debt service obligations, stock repurchases, and other general corporate purposes.
At September 30, 2026 and December 31, 2025, working capital was $1.1 billion and $878.6 million, respectively. At September 30, 2026 our cash and cash equivalents and restricted cash totaled $566.2 million.
We believe that cash generated from operations, together with existing cash balances, and amounts available under our Revolving Credit Facility, will be sufficient to fund our operating requirements, capital expenditures, debt service obligations, and other anticipated liquidity needs for at least the next twelve months.
Financing Transactions
During the three months ended September 30, 2026, the Company completed the financing transactions described below designed to enhance our financial flexibility, strengthen our long-term capital structure, and support future growth initiatives. Collectively, these transactions enhanced our capital structure by providing long-term financing, extending debt maturities, and increasing available liquidity while maintaining borrowing capacity under our Revolving Credit Facility.
In August 2026, we issued $375.0 million aggregate principal amount of 0.00% Convertible Senior Notes (“Convertible Senior Notes”) due 2031. Net proceeds from the offering were approximately $364.8 million, after deducting initial purchaser discounts, commissions, and offering expenses and prior to giving effect to the cost of the Capped Call Transactions described below. We used approximately $21.9 million to fund the Capped Call Transactions, and approximately $35.0 million for concurrent repurchases of our common stock. The remaining proceeds are available for general corporate purposes, including potential future acquisitions.
The issuance of the Convertible Senior Notes significantly increased our available liquidity and provided a long-term source of capital with no scheduled cash interest payments. As a result we are able to preserve our substantial cash balances while maintaining capacity under our Revolving Credit Facility for future operating, investing, and strategic activities.
Concurrently with the issuance of the Convertible Senior Notes, we entered into Capped Call Transactions intended to reduce potential dilution associated with conversions of the Convertible Senior Notes, subject to the terms of the transactions. The aggregate premium paid for the Capped Call Transactions was approximately $21.9 million.
Credit Agreement Amendment
Also during August 2026, we amended our Credit Agreement, extending the maturity date of our Revolving Credit Facility to August 12, 2031, modifying pricing provisions, permitting the Convertible Senior Notes financing, and revising certain financial and negative covenants. The amended facility continues to provide an important source of committed liquidity and financial flexibility. There were no borrowings outstanding under the Credit Agreement at September 30, 2026.
Undistributed Foreign Earnings
Our undistributed foreign earnings continue to be indefinitely reinvested in foreign operations, with limited exceptions related to earnings of certain European and Asian subsidiaries. As of September 30, 2026, our foreign subsidiaries held approximately $250.0 million of cash, cash equivalents and investments of which approximately $98.6 million would be subject to a potential non-U.S. withholding tax if distributed outside the country in which the cash is currently held. The $98.6 million is held in Asia and Europe.
Our Asia subsidiaries maintain short-term credit facilities with various financial institutions totaling $150.0 million. At September 30, 2026, the unused and available credit under the various facilities was approximately $128.5 million, net of $21.0 million advanced under our foreign credit lines and $0.4 million of credit used for import and export guarantee. These facilities provide additional liquidity to support local operating requirements.
At September 30, 2026, there was no outstanding balance under the Credit Agreement and approximately $225.0 million remained available for borrowing. In August 2026, we amended the Credit Agreement, extending the maturity or the Revolving Credit Facility to
-32-
August 12, 2031 and modifying certain terms to provide additional financial flexibility. The Credit Agreement contains customary affirmative and negative covenants, including a maximum leverage ratio and a minimum interest coverage ratio. As of September 30, 2026, we were in compliance with all financial covenants under the facility.
In August 2026, we issued $375.0 million aggregate principal amount of 0.00% Convertible Senior Notes due 2031. The issuance provided long-term capital, increased available liquidity, and preserves the borrowing capacity under our Revolving Credit Facility. The Convertible Senior Notes do not bear regular interest and, unless earlier converted, redeemed, or repurchased, mature on August 15, 2031.
Additionally, our 53% owned subsidiary, ERIS, had long-term debt of $17.5 million and $25.0 million, at September 30, 2026 and December 31, 2025, respectively, from local Taiwan banks. These borrowings mature at various dates through 2033.
Because some of our outstanding debt is subject to variable interest rates, higher interest rates will potentially increase our overall debt service cost. If interest rates rise globally, our cost of capital may increase in the future.
Discussion of Cash Flows
The table below sets forth a summary of the condensed consolidated statements of cash flows:
Operating Activities
Net cash flows from operating activities for the nine months ended September 30, 2026 was $229.9 million. The following recurring operating items gave rise to the calculation of net cash flows from operating activities for the nine months ended September 30, 2026: Net income of $111.4 million, depreciation and amortization of intangible assets of $106.3 million, share-based compensation of $28.3 million, and a net increase of $2.9 million of changes in working capital accounts. These increases in cash were partially offset by the recognition of net investment gains of $9.2 million and interest income from derivative instruments of $8.4 million.
Net cash flows from operating activities for the nine months ended September 30, 2025 was $177.4 million. The following recurring operating items gave rise to the calculation of net cash flows from operating activities for the nine months ended September 30, 2025: Net income of $56.9 million, depreciation and amortization of intangible assets of $108.5 million, a net increase of $43.3 million of changes in working capital accounts, and share-based compensation of $19.0 million. During the nine months ended September 30, 2025, the Company also recognized net investment gains of $27.6 million, including a $33.3 million non-cash mark-to-market increase in the value of the Company’s investment in Atlas, a non-cash mark-to-market decrease of $5.5 million of previously made equity investments, and a gain on the disposal of a subsidiary for $13.7 million.
Investing Activities
Net cash and cash equivalents from investing activities was $(344.9) million for the nine months ended September 30, 2026. Net cash and cash equivalents from investing activities for the nine months ended September 30, 2026 was primarily due to the purchase of ElevATE that used $262.3 million of cash, and purchases of property, plant, and equipment of $118.7 million, or 8.6% of net sales. We expect capital expenditures for the twelve months ending December 31, 2026 to be within our target model of 5% to 9% of net sales. The Company also received approximately $7.7 million due to the termination of a hedge instrument and made a $2.4 million payment from an escrow account related to the previously made acquisition.
Net cash and cash equivalents from investing activities was $(94.0) million for the nine months ended September 30, 2025. Net cash and cash equivalents from investing activities for the nine months ended September 30, 2025 was primarily due to purchases of property, plant, and equipment of $52.7 million, or 4.8% of net sales. The Company made purchases of equity securities of $49.3 million, including making an investment in ATX of approximately $30.0 million, increasing its investment in Atlas by approximately $17.3 million, and the acquisition of the minority interest in a joint venture in Taiwan for approximately $4.1 million, bringing the Company’s ownership to 100%. The Company also paid approximately $6.6 million due to the expiration of a hedge instrument. These uses of cash for investing were partially offset by the receipt of approximately $16.0 million related to the sale of TFS.
Financing Activities
Net cash and cash equivalents from financing activities was $302.1 million for the nine months ended September 30, 2026. The change primarily reflects the issuance of $375.0 million of Convertible Senior Notes, net of $10.2 million in debt issuance costs, partially
-33-
offset by $21.9 million for the Capped Call Transactions and approximately $45.2 million used to repurchase the Company’s common stock.
Net cash and cash equivalents from financing activities was $(30.8) million for the nine months ended September 30, 2025. Net cash from financing activities in the nine months ended September 30, 2025 consisted of net decreases in noncontrolling interests of $18.0 million, stock repurchases of $10.0 million, $1.6 million of net decreases in our debt, and taxes paid on net share settlements of $4.3 million.
Use of Derivative Instruments and Hedging
We use, or may use, interest rate swaps, commodity swaps, foreign exchange forward contracts, and cross currency swaps to provide a level of protection against interest rate risks and foreign exchange exposure.
Hedges of Commodity Risk
As part of our overall risk management strategy, we enter into commodity swap contracts to manage our exposure to fluctuations in commodity prices. These derivative instruments are intended to reduce the volatility of future cash flows attributable to changes in market prices and to provide greater certainty regarding the cost of commodities used in our operations.
Hedges of Interest Rate Risk
Our objectives in using interest rate derivatives are to add stability to interest expense and to manage exposure to interest rate movements. To accomplish these objectives, we primarily use interest rate swaps, including interest rate collars, as part of our interest rate risk management strategy. Interest rate swaps designated as cash flow hedges involve the receipt of variable amounts from a counterparty in exchange for us making fixed-rate payments over the life of the contracts without exchange of the underlying notional amount.
Hedges of Foreign Currency Risk
We are exposed to fluctuations in various foreign currencies against our different functional currencies. We use foreign currency forward contracts to manage this exposure and to preserve the economic value of foreign currency denominated monetary assets and liabilities. These instruments are not designated for hedge accounting treatment in accordance with ASC No. 815. The fair value of our foreign exchange hedges approximates zero.
Hedges of Net Investment Risk
We make use of cross-currency swaps and foreign-currency forward contracts to decrease the foreign exchange risk inherent in our investment in some of our foreign subsidiaries.
Off-Balance Sheet Arrangements
We do not have any transactions, arrangements, or other relationships with unconsolidated entities that will affect our liquidity or capital resources. We have no special purpose entities that provide off-balance sheet financing, liquidity, or market or credit risk support, nor do we engage in leasing, swap contracts, or outsourcing of research and development services that could expose us to liability that is not reflected on the face of our financial statements.
Contractual Obligations
There have been no material changes in our Contractual Obligations as disclosed in our Annual Report on Form 10-K for the fiscal year ended December 31, 2025, filed with the SEC on February 10, 2026.
Critical Accounting Estimates
Our critical accounting estimates are described in Item 7, Management’s Discussion and Analysis of Financial Condition and Results of Operations, and in the notes to our consolidated financial statements contained in our Annual Report on Form 10-K for the fiscal year ended December 31, 2025, filed with the SEC on February 10, 2026. Any new accounting estimates or updates to existing accounting estimates as a result of new accounting pronouncements have been discussed in the notes to our condensed consolidated financial statements in this Quarterly Report on Form 10-Q in Note 1 – Summary of Operations and Significant Accounting Policies. The application of our critical accounting estimates may require management to make judgments and estimates about the amounts reflected in the condensed consolidated financial statements. Management uses historical experience and all available information to make these estimates and judgments, and different amounts could be reported using different assumptions and estimates.
See Note 1 - Summary of Operations and Significant Accounting Policies, of the Notes to Condensed Consolidated Financial Statements, for detailed information regarding the status of recently issued accounting pronouncements, if any.
-34-
Item 3. Quantitative and Qualitative Disclosures About Market Risk.
Commodity Price Risk
We are exposed to commodity price risk in the ordinary course of business, including fluctuations in the market price of gold, which is used in our operations and may affect our cost of sales, margins, cash flows and financial condition. Gold prices are influenced by a number of factors beyond our control, including global supply and demand conditions, inflation expectations, interest rates, currency movements, investor demand, central bank activity, geopolitical developments and broader macroeconomic conditions. Significant increases in the price of gold could adversely affect our operating results to the extent we are unable to offset higher costs through pricing actions, productivity improvements, material substitutions or other measures.
To help manage a portion of our exposure to changes in gold prices, we enter into commodity hedging arrangements from time to time, including derivative instruments linked to gold prices. These arrangements are intended to reduce the variability of cash flows and earnings associated with forecasted purchases or usage of gold, but they may not fully offset the effects of commodity price changes and may expose us to basis risk, counterparty risk, liquidity risk and the risk that hedge positions do not qualify for, or are not designated for, hedge accounting treatment. In addition, the timing and amount of gains or losses recognized on these instruments may not coincide with the timing and amount of the underlying commodity exposures.
A hypothetical 10.0% increase or decrease in the market price of gold, measured as of September 30, 2026 and assuming the aggregate notional amount of our gold-related hedging positions and underlying forecasted exposures remained constant, would be expected to result in a corresponding change in the fair value of our gold commodity derivatives and in the cost of our forecasted gold purchases. The actual impact on our consolidated financial statements would depend on a variety of factors, including the notional amount, tenor and structure of our hedging instruments, the volume and timing of underlying gold purchases, whether the instruments are designated as cash flow hedges, and the extent to which any change in derivative fair value offsets changes in the cost of the underlying exposure. Accordingly, while our hedging program is intended to mitigate the effect of changes in gold prices, it does not eliminate commodity price risk.
Item 4. Controls and Procedures.
Our Chief Executive Officer, Gary Yu, and Chief Financial Officer, Brett R. Whitmire, with the participation of our management, carried out an evaluation, as of September 30, 2026, of the effectiveness of our disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)). Based upon that evaluation, the Chief Executive Officer and the Chief Financial Officer believe that, as of the end of the period covered by this Quarterly Report on Form 10-Q, our disclosure controls and procedures are effective at the reasonable assurance level to ensure that information required to be included in this Quarterly Report is:
Disclosure controls and procedures, no matter how well designed and implemented, can provide only reasonable assurance of achieving an entity’s disclosure objectives. The likelihood of achieving such objectives is affected by limitations inherent in disclosure controls and procedures. These include the fact that human judgment in decision-making can be faulty and that breakdowns in internal control can occur because of human failures such as simple errors, mistakes, or intentional circumvention of the established processes.
Changes in Internal Control over Financial Reporting
On August 27, 2026, the Company acquired ElevATE Semiconductor. Management excluded ElevATE from its assessment of internal control over financial reporting as of September 30, 2026. This exclusion is in accordance with SEC guidance that permits an acquired business to be omitted from management's assessment of internal control over financial reporting during the first year following an acquisition. ElevATE represented approximately $265.0 million of total assets and $1.9 million of revenue included in the Company's consolidated financial statements as of and for the period ended September 30, 2026. Other than activities related to the integration of ElevATE, there were no changes in the Company's internal control over financial reporting during the quarter that materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting.
-35-
PART II—OTHER INFORMATION
Item 1. Legal Proceedings.
The Company is not a party to any pending litigation that we consider material.
From time to time, we are involved in various legal proceedings that arise in the normal course of business. While we intend to defend any lawsuit vigorously, we presently believe that the ultimate outcome of any pending legal proceeding will not have any material adverse effect on our financial position, cash flows, or operating results. However, litigation is subject to inherent uncertainties, and unfavorable rulings could occur. An unfavorable ruling could include monetary damages, which could impact our business and operating results for the period in which the ruling occurs or future periods.
Item 1A. Risk Factors.
There have been no material changes to our risk factors from those disclosed in the Risk Factors section of our Annual Report on Form 10-K for the year ended December 31, 2025, filed with the Securities and Exchange Commission on February 10, 2026 exceptas follows:
We may not have the ability to raise the funds necessary to settle conversions of our Convertible Senior Notes or to repurchase our Convertible Senior Notes upon a fundamental change, and our Credit Agreement contains, and any future debt may also contain, limitations on our ability to pay cash upon conversion or repurchase of our Convertible Senior Notes.
Holders of our Convertible Senior Notes have the right, subject to certain conditions and limited exceptions, to require us to repurchase all or a portion of their Convertible Senior Notes upon the occurrence of a fundamental change (as defined in the Indenture) at a fundamental change repurchase price equal to 100% of the principal amount of our Convertible Senior Notes to be repurchased, plus accrued and unpaid interest, if any, to, but excluding, the fundamental change repurchase date. In addition, upon any conversion of our Convertible Senior Notes, we will be required to make cash payments for each $1,000 in principal amount of our Convertible Senior Notes converted of at least the lesser of $1,000 and the sum of the daily conversion values as described in the Convertible Senior Notes Indenture. However, we may not have enough available cash or be able to obtain financing at the time we are required to make repurchases of our Convertible Senior Notes surrendered therefor or pay cash with respect to our Convertible Senior Notes being converted. In addition, our Credit Agreement prohibits us from making any cash payments on the conversion or repurchase of our Convertible Senior Notes if an event of default exists thereunder, making any cash payments upon a fundamental change or if, after giving effect to such conversion or repurchase (and any additional indebtedness incurred in connection with such conversion or a repurchase), we would not be in pro forma compliance with our financial covenants under that facility. Our ability to repurchase our Convertible Senior Notes or to pay cash upon conversions of our Convertible Senior Notes may be limited by law, by regulatory authority or by agreements governing our future indebtedness. Our failure to repurchase our Convertible Senior Notes at a time when the repurchase is required by the Indenture or to pay any cash payable on future conversions of our Convertible Senior Notes as required by the Indenture would constitute a default under the Indenture. A default under the Indenture or the fundamental change itself could also lead to a default under agreements governing our indebtedness. If the repayment of the related indebtedness were to be accelerated after any applicable notice or grace periods, we may not have sufficient funds to repay the indebtedness and repurchase our Convertible Senior Notes or make cash payments upon conversions thereof.
The conditional conversion feature of our Convertible Senior Notes, if triggered, may adversely affect our financial condition and operating results.
In the event the conditional conversion feature of our Convertible Senior Notes is triggered, holders of our Convertible Senior Notes will be entitled to convert their notes at any time during specified periods at their option. If one or more holders elect to convert their notes, we would be required to settle any converted principal amount of such notes through the payment of cash, which could adversely affect our liquidity. In addition, even if holders do not elect to convert their notes, we could be required under applicable accounting rules to reclassify all or a portion of the outstanding principal of our Convertible Senior Notes as a current rather than long-term liability, which would result in a material reduction of our working capital.
Conversion of our Convertible Senior Notes may dilute the ownership interest of our stockholders or may otherwise depress the price of our common stock.
The conversion of some or all of our Convertible Senior Notes may dilute the ownership interests of our stockholders. Upon conversion of our Convertible Senior Notes, we have the option to pay or deliver, as the case may be, cash, shares of our common stock, or a combination of cash and shares of our common stock in respect of the remainder, if any, of our conversion obligation in excess of the aggregate principal amount of our Convertible Senior Notes being converted. If we elect to settle the remainder, if any, of our conversion obligation in excess of the aggregate principal amount of our Convertible Senior Notes being converted in shares of our common stock or a combination of cash and shares of our common stock, any sales in the public market of our common stock issuable upon such conversion could adversely affect prevailing market prices of our common stock. In addition, the existence of our Convertible Senior Notes may encourage short selling by market participants because the conversion of our Convertible Senior Notes could be used
-36-
to satisfy short positions, or anticipated conversion of our Convertible Senior Notes into shares of our common stock could depress the price of our common stock.
Changes in the accounting method for convertible debt securities that may be settled in cash, such as our Convertible Senior Notes, could adversely affect our reported financial condition and results.
The accounting method for reflecting our Convertible Senior Notes on our balance sheet, accruing interest expense for our Convertible Senior Notes and reflecting the underlying shares of our common stock in our reported diluted earnings per share may adversely affect our reported earnings and financial condition.
In August 2020, the Financial Accounting Standards Board published ASU 2020-06, which simplifies certain of the accounting standards that apply to convertible notes. In accordance with ASU 2020-06, our Convertible Senior Notes are reflected as a liability on our balance sheets, with the initial carrying amount equal to the principal amount of our Convertible Senior Notes, net of issuance costs. The issuance costs were treated as a debt discount for accounting purposes, which will be amortized into interest expense over the term of our Convertible Senior Notes. As a result of this amortization, the interest expense that we expect to recognize for our Convertible Senior Notes for accounting purposes will be greater than the cash interest payments we will pay on our Convertible Senior Notes, which will result in lower reported net income.
In addition, the shares of our common stock underlying our Convertible Senior Notes are reflected in our diluted earnings per share using the “if converted” method, in accordance with ASU 2020-06. Under that method, diluted earnings per share generally are calculated assuming that all of our Convertible Senior Notes were converted into cash and shares of common stock at the beginning of the reporting period based on the average market price of common stock determined in accordance with applicable accounting rules, unless the result would be anti-dilutive. The application of the if-converted method may reduce our reported diluted earnings per share.
Furthermore, if any of the conditions to the convertibility of our Convertible Senior Notes is satisfied, then we may be required under applicable accounting standards to reclassify the liability carrying value of our Convertible Senior Notes as a current, rather than a long-term, liability. This reclassification could be required even if no noteholders convert their notes and could materially reduce our reported working capital.
Certain provisions in the Indenture governing the Convertible Senior Notes may delay or prevent an otherwise beneficial takeover attempt of us.
Certain provisions in the Indenture may make it more difficult or expensive for a third party to acquire us. For example, the Indenture will require us, subject to limited exceptions, to repurchase our Convertible Senior Notes for cash upon the occurrence of a fundamental change and, in certain circumstances, to increase the conversion rate for a holder that converts its Convertible Senior Notes in connection with a make-whole fundamental change. A takeover of us may trigger the requirement that we repurchase our Convertible Senior Notes and/or increase the conversion rate, which could make it costlier for a potential acquirer to engage in such takeover. Such additional costs may have the effect of delaying or preventing a takeover of us that would otherwise be beneficial to investors.
The Capped Call Transactions may affect the value of our common stock.
In connection with the issuance of our Convertible Senior Notes, we entered into the Capped Call Transactions with the option counterparties (the “option counterparties”). The Capped Call Transactions cover, subject to customary adjustments substantially similar to those applicable to our Convertible Senior Notes, the number of shares of our common stock initially underlying our Convertible Senior Notes. The Capped Call Transactions are expected generally to reduce the potential dilution to our common stock upon any conversion of our Convertible Senior Notes and/or offset any cash payments we are required to make in excess of the principal amount of converted notes, as the case may be, with such reduction and/or offset subject to a cap.
The option counterparties or their respective affiliates may modify their hedge positions by entering into or unwinding various derivatives with respect to our common stock and/or purchasing or selling our common stock or other securities of ours in secondary market transactions following the pricing of our Convertible Senior Notes and prior to the maturity of our Convertible Senior Notes (and are likely to do so during any observation period related to a conversion of our Convertible Senior Notes or, to the extent we exercise the relevant election under the Capped Call Transactions, following any repurchase or redemption of our Convertible Senior Notes). This activity could also cause or avoid an increase or a decrease in the market price of our common stock.
We are subject to counterparty risk with respect to the Capped Call Transactions.
The option counterparties are financial institutions, and we will be subject to the risk that one or more of the option counterparties may default or otherwise fail to perform, or may exercise certain rights to terminate, their obligations under the Capped Call Transactions. Our exposure to the credit risk of the option counterparties will not be secured by any collateral.
Global economic conditions have from time to time resulted in the actual or perceived failure or financial difficulties of many financial institutions and could adversely affect the option counterparties’ performance under the Capped Call Transactions. If an option counterparty becomes subject to insolvency proceedings, we will become an unsecured creditor in those proceedings with a claim equal to our exposure at that time under the Capped Call Transactions with such option counterparty. Our exposure will depend on many
-37-
factors but, generally, our exposure will increase if the market price or the volatility of our common stock increases. In addition, upon a default or other failure to perform, or a termination of obligations, by an option counterparty, we may suffer adverse tax consequences or more dilution than we currently anticipate with respect to our common stock. We can provide no assurances as to the financial stability or viability of the option counterparties.
In addition, the terms of the Capped Call Transactions may be subject to adjustment, modification or, in some cases, renegotiation in the event of certain corporate and other transactions. The Capped Call Transactions may not operate as we intend in the event that we are required to adjust the terms of such instruments as a result of transactions in the future or in the event of other unanticipated developments that may adversely affect the functioning of the Capped Call Transactions.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.
The following table provides information about repurchases of our common stock during the three months ended September 30, 2026.
(a)
(b)
(c)
(d)
Period
Total Number of Shares Purchased
Average Price Paid per Share
Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs
Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs
July 1, 2026 - July 31, 2026
56,184,423
August 1, 2026 - August 31, 2026
360,119
21,184,457
September 1, 2026 - September 30, 2026
Concurrently with the pricing of our Convertible Senior Notes in August 2026, we entered into a share repurchase transaction with one of the initial purchasers of Convertible Senior Notes or its affiliate, pursuant to which we repurchased 360,119 shares of common stock in a privately negotiated transaction at a purchase price of $97.19 per share, for an aggregate purchase price of approximately $35.0 million. The share repurchase transaction, which was the only repurchase of our common stock during the quarter, was made under the authorization received from our board of directors on May 8, 2025, to purchase up to $100.0 million of the Company’s common stock. As of September 30, 2026, $78.8 million of the May 2025 program had been utilized. Share repurchases under the program may be made from time to time in the open market, through privately-negotiated transactions, or otherwise, subject to applicable laws, regulations, and approvals. The timing of the share repurchases will depend on a variety of factors, including market conditions, and the share repurchases may be suspended or discontinued at any time.
Item 3. Defaults Upon Senior Securities.
None.
Item 4. Mine Safety Disclosures.
Not applicable.
Item 5. Other Information.
Insider Trading Arrangements
During the quarter ended September 30, 2026, no director or officer adopted or terminated a Rule 10b5-1 trading arrangement or a non-Rule 10b5-1 trading arrangement, except as follows:
On August 20, 2026, Evan Yu, an independent member of the Company’s board of directors, entered into a trading plan intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Securities Exchange Act of 1934. The plan provides for the sale of up to 3,500 shares of the Company’s common stock, subject to the terms of the plan, during the period from October 12, 2026 (and not before such date) through August 20, 2027. Mr. Yu’s plan will expire on August 20, 2027, subject to early termination in accordance with the terms of the plan.
-38-
Item 6. Exhibits.
Number
Form
Date of First Filing
ExhibitNumber
FiledHerewith
2.1*
Agreement and Plan of Merger, dated as of July 10, 2026, by and among Diodes Incorporated, GN Merger Sub Inc., Elevate Semiconductor, Inc., and Presidio Investors ELV Continuation GP, LLC, solely in its capacity as Equityholders’ Representative.
8-K
July 14, 2026
2.1
3.1
Certificate of Incorporation, as amended
10-K
February 20, 2018
3.2
Amended By-laws of the Company as of January 6, 2016
January 11, 2016
4.1
Form of Certificate for Common Stock, par value $0.66 2/3 per share
S-3
August 25, 2005
4.2
Indenture, dated as of August 18, 2026, by and between Diodes Incorporated and U.S. Bank Trust Company, National Association, as Trustee (including the form of the Notes attached thereto as Exhibit A).
August 18, 2026
4.3
Form of Global Note representing Diodes Incorporated’s 0.00% Convertible Senior Notes due 2031 (included as Exhibit A to the Indenture filed as Exhibit 4.1).
10.1*
Amendment No. 1 to Third Amended and Restated Credit Agreement, dated as of August 12, 2026, by and among Diodes Incorporated, Diodes Holding UK Limited, certain subsidiaries of Diodes Incorporated party thereto, Bank of America, N.A., as Administrative Agent, and the Lenders party thereto.
10.1
10.2
Form of Confirmation for Capped Call Transactions.
31.1
Certification Pursuant to Rule 13a-14(a)/15d-14(a) of the Securities Exchange Act of 1934, adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
X
31.2
Certification Pursuant to Rule 13a-14(a) /15d-14(a) of the Securities Exchange Act of 1934, adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1**
Certification Pursuant to 18 U.S.C. 1350 adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2**
101.INS
Inline XBRL Instance Document- the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
101.SCH
Inline XBRL Taxonomy Extension Schema
104
Cover Page Interactive Data File, formatted in Inline XBRL
*
Schedules and similar attachments have been omitted pursuant to Item 601(a)(5) of Regulation S-K. A copy of any omitted schedule will be furnished supplementally to the SEC upon request.
**
A certification furnished pursuant to Item 601(b)(32) of the Regulation S-K will not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of that section. Such certification will not be deemed to be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, except to the extent that the registrant specifically incorporates it by reference.
PLEASE NOTE: It is inappropriate for investors to assume the accuracy of any covenants, representations or warranties that may be contained in agreements or other documents filed as exhibits to this Quarterly Report on Form 10-Q. In certain instances the disclosure
-39-
schedules to such agreements or documents contain information that modifies, qualifies and creates exceptions to the representations, warranties and covenants. Moreover, some of the representations and warranties may not be complete or accurate as of a particular date because they are subject to a contractual standard of materiality that is different from those generally applicable to stockholders and/or were used for the purpose of allocating risk among the parties rather than establishing certain matters as facts. Accordingly, you should not rely on the representations and warranties as characterizations of the actual state of facts at the time they were made or otherwise.
-40-
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Quarterly Report to be signed on its behalf by the undersigned thereunto duly authorized.
(Registrant)
November 5, 2026
By: /s/ Gary Yu
Date
GARY YU
President and Chief Executive Officer
(Principal Executive Officer)
By: /s/ Brett R. Whitmire
BRETT R. WHITMIRE
Chief Financial Officer
(Principal Financial Officer)
-41-